Summary
- Current Price
- As of today, ALDX price is $5.62, up +2.93% on
- Current Price All-Time High
- ALDX price is currently -66.35% below its historical high of $16.70 set on
- Market Cap
- ALDX current market cap is $338M, up +10.82% over the past 365 days
- PE Ratio
- ALDX PE ratio is unknown
- Revenue
- ALDX current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for ALDX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Aldeyra Therapeutics, Inc. |
| Ticker | NASDAQ: ALDX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | aldeyra.com |
| Employees | 8 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $5.62 | ||
| Price, 1D Change | +2.93% | |
| $338M | ||
| - | ||
| - | ||
| 1.01 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$0.56 | ||
| EPS, 1Y Change | +39.97% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.56 | ||
| EPS Estimate | N/A | $0.39 |
| EPS Est. Change | N/A | +169.20% |
| $0.00 | ||
| Revenue Estimate | N/A | $63.59M |
| Revenue Est. Change | N/A | - |
| $5.62 | ||
| Price Target | - | $9.50 |
| Price Tgt. Change | - | +69.04% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.91 | -$0.94 | -2.86% | |
| -$0.60 | -$0.56 | +5.28% | |
| $0.39 | N/A | +169.20% | |
| $0.31 | N/A | +155.59% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| $24.25M | $0.00 | -100.00% | |
| $63.59M | N/A | - | |
| $84.63M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +9.98% | ||
| -25.07% | ||
| +10.82% | ||
| -23.02% | ||
| 0.00% | ||
| 0.00% | ||
| +39.97% | ||
| +46.93% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $5.62 | ||
| $4.75 | ||
| SMA 200 vs Price | -15.55% | |
| $5.04 | ||
| SMA 50 vs Price | -10.35% | |
| 1.01 | ||
| $0.31 | ||
| 61.85 | ||
| 45.55% | ||
| 112.39% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$0.56 | ||
| -$252.00K | ||
| - | ||
| -$35.27M | ||
| - | ||
| -$33.85M | ||
| - | ||
| -$35.01M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.35 | ||
| 2.54 | ||
| 2.54 | ||
| - | ||
| - | ||
| -3.01 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 7.64 | ||
| - | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $44.25M | ||
| $70.04M | ||
| $72.06M | ||
| $70.74M | ||
| $27.81M | ||
| $27.81M | ||
| $15.53M | ||
| $15.53M | ||
| $158.50K |
Expenses
| Metric | Date | Value |
|---|---|---|
| $33.85M | ||
| $35.01M | ||
| $252.00K | ||
| $0.00 | ||
| $252.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$33.35M | ||
| $47.74M | ||
| $1.12M | ||
| $0.00 | ||
| -$33.35M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| BTIG | → | |
| HC Wainwright & Co. | → | |
| BTIG | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Oppenheimer | → | |
| HC Wainwright & Co. | → | |
| Oppenheimer | → |
Analyst sentiment
Institutional ownership
Screeners with ALDX
FAQ
What is the ticker symbol for Aldeyra Therapeutics, Inc.?
The ticker symbol for Aldeyra Therapeutics, Inc. is NASDAQ:ALDX
Does Aldeyra Therapeutics, Inc. pay dividends?
No, Aldeyra Therapeutics, Inc. does not pay dividends
What sector is Aldeyra Therapeutics, Inc. in?
Aldeyra Therapeutics, Inc. is in the Healthcare sector
What industry is Aldeyra Therapeutics, Inc. in?
Aldeyra Therapeutics, Inc. is in the Biotechnology industry
What country is Aldeyra Therapeutics, Inc. based in?
Aldeyra Therapeutics, Inc. is headquartered in United States
When did Aldeyra Therapeutics, Inc. go public?
Aldeyra Therapeutics, Inc. initial public offering (IPO) was on May 2, 2014
Is Aldeyra Therapeutics, Inc. in the S&P 500?
No, Aldeyra Therapeutics, Inc. is not included in the S&P 500 index
Is Aldeyra Therapeutics, Inc. in the NASDAQ 100?
No, Aldeyra Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Aldeyra Therapeutics, Inc. in the Dow Jones?
No, Aldeyra Therapeutics, Inc. is not included in the Dow Jones index
When was Aldeyra Therapeutics, Inc. last earnings report?
Aldeyra Therapeutics, Inc.'s most recent earnings report was on November 13, 2025
When does Aldeyra Therapeutics, Inc. report earnings?
The next expected earnings date for Aldeyra Therapeutics, Inc. is March 5, 2026
Data Sources & References
- ALDX Official Website www.aldeyra.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1341235/000119312526083012/0001193125-26-083012-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1341235/000119312526083012/0001193125-26-083012-index.htm
- ALDX Profile on Yahoo Finance finance.yahoo.com/quote/ALDX
- ALDX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/aldx